600664.SS · 哈药股份
China A-shares · RS rating 90 · As of 2026-10-14
| Price | 6.16 CNY |
|---|---|
| 1-day change | -6.1% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 5 / 99 / 94 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 36 / 35 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +5.9% |
| Distance from 52-week high | +35.1% |
| Market cap (USD) | $2.7B |